Skip to main content
Top
Published in: BMC Cancer 1/2015

Open Access 01-12-2015 | Research article

Micro actions in colorectal cancer screening participation: a population-based survey study

Authors: Siu Hing Lo, Jo Waller, Charlotte Vrinten, Christian von Wagner

Published in: BMC Cancer | Issue 1/2015

Login to get access

Abstract

Background

Low uptake of colorectal cancer (CRC) screening is a cause for concern. This study explored people’s anticipated response to receiving the test kit to shed light on past screening uptake and help inform future interventions to increase participation.

Methods

Face-to-face interviews were conducted with respondents living in England who were eligible for CRC screening as part of a population-based ‘omnibus’ survey. Respondents were asked what they would do (‘micro actions’) if they received a CRC screening test kit through the mail (apart from completing it or not), and their unprompted responses were coded (multiple codes allowed). Past ‘ever’ uptake and screening intention were also recorded. The final analysis included 1237 respondents aged 60–70.

Results

Respondents who said that they would decide after some thought’ (p < .001), ‘put [it] aside to deal with later’ (p < .001), ‘put it on the “to do list/ pile”’ (p < .05) or ‘discuss it with a health care professional’ (p < .01) had decreased odds of having participated. Those who said they would ‘read the instruction leaflet’ (p < .001), ‘put the kit near the toilet’ (p < .001) or ‘decide when to do the test’ (p < .05) were more likely to have taken part in CRC screening. With the exception of ‘decide when to do the test’ and ‘discuss it with a health care professional’, all associations with past uptake remained significant after adjusting for other micro actions and screening intention. ‘Make a note somewhere (to remind myself)’ was mentioned by less than 1 % of respondents.

Conclusions

Delay-causing and preparatory micro actions were associated with past CRC screening uptake. Self-regulatory micro actions (e.g. making a note to remind oneself) were rarely mentioned as responses to receiving a screening invitation. Interventions aimed at reducing delay and facilitating preparatory and self-regulatory behaviours might help increase uptake. The behaviour-focused survey method is a promising avenue for future health behaviour research.
Literature
1.
go back to reference Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103:1541–9.CrossRefPubMed Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103:1541–9.CrossRefPubMed
2.
go back to reference Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD. Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut. 2002;50:840–4.CrossRefPubMedPubMedCentral Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD. Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut. 2002;50:840–4.CrossRefPubMedPubMedCentral
3.
go back to reference Von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol. 2011;40:712–8.CrossRefPubMed Von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol. 2011;40:712–8.CrossRefPubMed
4.
go back to reference Lo SH, Halloran S, Snowball J, Seaman H, Wardle J, Von Wagner C. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme. Gut. 2014;64:282–91.CrossRefPubMedPubMedCentral Lo SH, Halloran S, Snowball J, Seaman H, Wardle J, Von Wagner C. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme. Gut. 2014;64:282–91.CrossRefPubMedPubMedCentral
5.
go back to reference Kiviniemi MT, Bennett A, Zaiter M, Marshall JR. Individual-level factors in colorectal cancer screening: a review of the literature on the relation of individual-level health behavior constructs and screening behavior. Psycho-Oncol. 2011;20:1023–33.CrossRef Kiviniemi MT, Bennett A, Zaiter M, Marshall JR. Individual-level factors in colorectal cancer screening: a review of the literature on the relation of individual-level health behavior constructs and screening behavior. Psycho-Oncol. 2011;20:1023–33.CrossRef
6.
go back to reference Taskila T, Wilson S, Damery S, Roalfe A, Redman V, Ismail T, et al. Factors affecting attitudes toward colorectal cancer screening in the primary care population. Brit J Cancer. 2009;101:250–5.CrossRefPubMedPubMedCentral Taskila T, Wilson S, Damery S, Roalfe A, Redman V, Ismail T, et al. Factors affecting attitudes toward colorectal cancer screening in the primary care population. Brit J Cancer. 2009;101:250–5.CrossRefPubMedPubMedCentral
7.
go back to reference Vart GF. How men differ from women in their attitudes towards bowel cancer screening and intention to be screened. J Mens Health. 2010;7:241–8.CrossRef Vart GF. How men differ from women in their attitudes towards bowel cancer screening and intention to be screened. J Mens Health. 2010;7:241–8.CrossRef
8.
go back to reference Gregory TA, Wilson C, Duncan A, Turnbull D, Cole SR, Young G. Demographic, social cognitive and social ecological predictors of intention and participation in screening for colorectal cancer. BMC Public Health. 2011;11:38.CrossRefPubMedPubMedCentral Gregory TA, Wilson C, Duncan A, Turnbull D, Cole SR, Young G. Demographic, social cognitive and social ecological predictors of intention and participation in screening for colorectal cancer. BMC Public Health. 2011;11:38.CrossRefPubMedPubMedCentral
9.
go back to reference Power E, Van Jaarsveld CHM, McCaffery K, Miles A, Atkin W, Wardle J. Understanding intentions and action in colorectal cancer screening. Ann Behav Med. 2008;35:285–94.CrossRefPubMed Power E, Van Jaarsveld CHM, McCaffery K, Miles A, Atkin W, Wardle J. Understanding intentions and action in colorectal cancer screening. Ann Behav Med. 2008;35:285–94.CrossRefPubMed
10.
go back to reference Lo SH, Waller J, Wardle J, Von Wagner C. Comparing barriers to colorectal cancer screening with barriers to breast and cervical screening: a population-based survey of screening-age women in Great Britain. J Med Screen. 2013;20:73–9.CrossRefPubMed Lo SH, Waller J, Wardle J, Von Wagner C. Comparing barriers to colorectal cancer screening with barriers to breast and cervical screening: a population-based survey of screening-age women in Great Britain. J Med Screen. 2013;20:73–9.CrossRefPubMed
11.
go back to reference Lo SH, Halloran S, Snowball J, Seaman H, Wardle J, Von Wagner C. Predictors of repeat participation in the NHS bowel cancer screening programme. Brit J Cancer. 2014;112:199–206.CrossRefPubMedPubMedCentral Lo SH, Halloran S, Snowball J, Seaman H, Wardle J, Von Wagner C. Predictors of repeat participation in the NHS bowel cancer screening programme. Brit J Cancer. 2014;112:199–206.CrossRefPubMedPubMedCentral
12.
go back to reference Gollwitzer PM. Implementation intentions-Strong effects of simple plans. Am Psychol. 1999;54:493–503.CrossRef Gollwitzer PM. Implementation intentions-Strong effects of simple plans. Am Psychol. 1999;54:493–503.CrossRef
13.
go back to reference Sheeran P, Aubrey R, Kellett S. Increasing attendance for psychotherapy: implementation intentions and the self-regulation of attendance-related negative affect. J Consult Clin Psych. 2007;75:853–63.CrossRef Sheeran P, Aubrey R, Kellett S. Increasing attendance for psychotherapy: implementation intentions and the self-regulation of attendance-related negative affect. J Consult Clin Psych. 2007;75:853–63.CrossRef
14.
go back to reference Gollwitzer PM, Sheeran P. Implementation intentions and goal achievement: A meta-analysis of effects and processes. Adv Exp Soc Psychol. 2006;38:69–119.CrossRef Gollwitzer PM, Sheeran P. Implementation intentions and goal achievement: A meta-analysis of effects and processes. Adv Exp Soc Psychol. 2006;38:69–119.CrossRef
15.
go back to reference Hagger MS, Luszczynska A. Implementation Intention and Action Planning Interventions in Health Contexts: State of the Research and Proposals for the Way Forward. Appl Psychol-Health and Well Being. 2014;6:1–47.CrossRef Hagger MS, Luszczynska A. Implementation Intention and Action Planning Interventions in Health Contexts: State of the Research and Proposals for the Way Forward. Appl Psychol-Health and Well Being. 2014;6:1–47.CrossRef
16.
go back to reference Lo SH, Good A, Sheeran P, Baio G, Rainbow S, Vart G, et al. Pre-formulated implementation intentions to promote colorectal cancer screening: a cluster-randomized trial. Health Psychol. 2013;33:998–1002.CrossRefPubMed Lo SH, Good A, Sheeran P, Baio G, Rainbow S, Vart G, et al. Pre-formulated implementation intentions to promote colorectal cancer screening: a cluster-randomized trial. Health Psychol. 2013;33:998–1002.CrossRefPubMed
17.
go back to reference Neter E, Stein N, Barnett-Griness O, Rennert G, Hagoel L. From the Bench to Public Health Population-level Implementation Intentions in Colorectal Cancer Screening. Am J Prev Med. 2014;46:273–80.CrossRefPubMed Neter E, Stein N, Barnett-Griness O, Rennert G, Hagoel L. From the Bench to Public Health Population-level Implementation Intentions in Colorectal Cancer Screening. Am J Prev Med. 2014;46:273–80.CrossRefPubMed
19.
go back to reference Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37:360–3.PubMed Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37:360–3.PubMed
20.
go back to reference StataCorp. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP; 2013. StataCorp. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP; 2013.
21.
go back to reference Statistics OfN. Focus on Ethnicity and Identity, Summary Report. In: Office for National Statistics. 2005. Statistics OfN. Focus on Ethnicity and Identity, Summary Report. In: Office for National Statistics. 2005.
22.
go back to reference Greiner KA, Daley CM, Epp A, James A, Yeh H-W, Geana M, et al. Implementation Intentions and Colorectal Screening A Randomized Trial in Safety-Net Clinics. Am J Prev Med. 2014;47:703–14.CrossRefPubMedPubMedCentral Greiner KA, Daley CM, Epp A, James A, Yeh H-W, Geana M, et al. Implementation Intentions and Colorectal Screening A Randomized Trial in Safety-Net Clinics. Am J Prev Med. 2014;47:703–14.CrossRefPubMedPubMedCentral
23.
go back to reference De Bruin M, Sheeran P, Kok G, Hiemstra A, Prins JM, Hospers HJ, et al. Self-Regulatory Processes Mediate the Intention-Behavior Relation for Adherence and Exercise Behaviors. Health Psychol. 2012;31:695–703.CrossRefPubMed De Bruin M, Sheeran P, Kok G, Hiemstra A, Prins JM, Hospers HJ, et al. Self-Regulatory Processes Mediate the Intention-Behavior Relation for Adherence and Exercise Behaviors. Health Psychol. 2012;31:695–703.CrossRefPubMed
Metadata
Title
Micro actions in colorectal cancer screening participation: a population-based survey study
Authors
Siu Hing Lo
Jo Waller
Charlotte Vrinten
Christian von Wagner
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2015
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-015-1465-9

Other articles of this Issue 1/2015

BMC Cancer 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine